-
公开(公告)号:EP4260846A1
公开(公告)日:2023-10-18
申请号:EP22168387.3
申请日:2022-04-14
发明人: SCHELLER, Lena , MEINEL, Lorenz , LUEHMANN, Tessa
摘要: The present invention relates to a composition comprising a metal-organic framework, one or more emulsifier(s) and one or more lipid(s). Furthermore, the present invention relates to a method for preparing a microemulsion in response to a physical- and/or chemical stimulus and to a method for increasing the solubility of a pharmaceutically active ingredient in a solvent and/or for improving the bioavailability of a pharmaceutically active ingredient and/or for preparing a self-microemulsifying drug delivery system. Finally, the present invention relates to the use of a composition comprising a metal-organic framework, one or more emulsifier(s) and one or more lipid(s) for preparing a microemulsion in response to a physical- and/or chemical stimulus and the use of the composition for increasing the solubility of a pharmaceutically active ingredient in a solvent and/or for improving the bioavailability of a pharmaceutically active ingredient and/or for preparing a self-microemulsifying drug delivery system.
-
公开(公告)号:EP4360658A1
公开(公告)日:2024-05-01
申请号:EP22204457.0
申请日:2022-10-28
发明人: MEINEL, Lorenz , TER MORS, Björn , DRIESSEN, Marc
CPC分类号: A61K49/0004 , C07K7/06 , C07K7/08
摘要: The present invention relates to novel protease-sensitive peptides, related compounds or salts thereof having the structure Den-R-NH-Pep (wherein Den is a denatonium residue and Pep designates a protease-sensitive peptide) as well as bioresponsive sensors comprising same, which may be used for diagnostic purposes, in particular for detection of inflammation, as well as to related methods and uses.
-
3.
公开(公告)号:EP3794025A1
公开(公告)日:2021-03-24
申请号:EP19724205.0
申请日:2019-05-17
发明人: MEINEL, Lorenz , LÜHMANN, Tessa , BRAUN, Alexandra
IPC分类号: C07K14/65 , A61K38/30 , C12N9/10 , A61K38/18 , C07K14/475
-
公开(公告)号:EP2823050B1
公开(公告)日:2017-03-01
申请号:EP13710333.9
申请日:2013-03-08
CPC分类号: A61K49/0004 , A23G4/14 , A61C2201/002 , A61K9/0058 , A61K49/00 , A61K49/0069 , C12Q1/04 , C12Q1/37 , C12Q2304/00 , G01N33/528 , G01N33/68 , G01N33/6893 , Y02A50/54 , Y02A50/58
摘要: Described herein is a diagnostic chewing gum for identifying the presence of pathogens detectable via the mouth, in particular pathogens residing in nasal, oropharyngeal, laryngeal, oesophageal, ocular and/or pulmonal tissue of a user, more particularly pathogens selected from among a virus, bacterium, protozoa, prion, fungus or a combination thereof. The inventive diagnostic chewing gum includes a base material or particles (3) embedded and/or attached to the base material and an element (1, 5-7), like e.g. a releasable flavor molecule, attached to the base material and/or the particles, for the generation of a change in the chewing gum directly detectable by the user, wherein the element (1, 5-7) generates the change upon direct or indirect contact with a marker (4) which is released by the pathogens, or, in case of a virus or prion, by the cellular structure hosting it.
-
公开(公告)号:EP2823050A1
公开(公告)日:2015-01-14
申请号:EP13710333.9
申请日:2013-03-08
CPC分类号: A61K49/0004 , A23G4/14 , A61C2201/002 , A61K9/0058 , A61K49/00 , A61K49/0069 , C12Q1/04 , C12Q1/37 , C12Q2304/00 , G01N33/528 , G01N33/68 , G01N33/6893 , Y02A50/54 , Y02A50/58
摘要: Described herein is a diagnostic chewing gum for identifying the presence of pathogens detectable via the mouth, in particular pathogens residing in nasal, oropharyngeal, laryngeal, oesophageal, ocular and/or pulmonal tissue of a user, more particularly pathogens selected from among a virus, bacterium, protozoa, prion, fungus or a combination thereof. The inventive diagnostic chewing gum includes a base material or particles (3) embedded and/or attached to the base material and an element (1, 5-7), like e.g. a releasable flavor molecule, attached to the base material and/or the particles, for the generation of a change in the chewing gum directly detectable by the user, wherein the element (1, 5-7) generates the change upon direct or indirect contact with a marker (4) which is released by the pathogens, or, in case of a virus or prion, by the cellular structure hosting it.
摘要翻译: 本文描述的是用于鉴定通过口可检测的病原体的存在的诊断性口香糖,特别是存在于使用者的鼻,口咽,喉,食管,眼和/或肺组织中的病原体,特别是选自病毒, 细菌,原生动物,朊病毒,真菌或其组合。 本发明的诊断口香糖包括嵌入和/或附着到基底材料的基底材料或颗粒(3)和元件(1,5-7) 连接到基材和/或颗粒上的可释放风味分子,用于产生用户可直接检测的口香糖的变化,其中元件(1,5-7)在直接或间接接触时产生变化 具有由病原体释放的标记物(4),或者在病毒或朊病毒的情况下由宿主的细胞结构产生。
-
公开(公告)号:EP4461738A1
公开(公告)日:2024-11-13
申请号:EP23172136.6
申请日:2023-05-08
摘要: The present invention relates to diagnostic furin sensors, respective furin sensitive peptides and related kits. The invention further relates to methods and medical uses involving said sensors, peptides or kits, such as methods for diagnosing cancer (particularly HNSCC), in a subject, as well as to methods for determining furin activity.
-
7.
公开(公告)号:EP3645559A1
公开(公告)日:2020-05-06
申请号:EP18748933.1
申请日:2018-08-07
发明人: BRAUN, Alexandra , MEINEL, Lorenz , LÜHMANN, Tessa
-
公开(公告)号:EP4045006A1
公开(公告)日:2022-08-24
申请号:EP20793297.1
申请日:2020-10-13
-
公开(公告)号:EP3808351A1
公开(公告)日:2021-04-21
申请号:EP19203033.6
申请日:2019-10-14
IPC分类号: A61K31/555 , A61K33/04 , A61K33/24 , A61K33/26 , A61K33/32 , A61K33/40 , A61K9/48 , A61K9/00 , A61K9/51 , A61P1/00 , A61P1/04 , A61P29/02 , A01N1/02
摘要: The present invention discloses a therapeutic gas release system for oral administration comprising a therapeutic gas releasing compound A, and a therapeutic gas release triggering compound B, wherein compound A and B are separated from each other by an inner septum during storage of the system, wherein compound A and B are surrounded by an outer membrane, which is a gas-permeable and water- and solid-impermeable membrane, preferably a silicone membrane, and wherein therapeutic gas release from the system is activated before oral administration by breaking the inner septum . The system of the present invention is suitable for the treatment of (inflammatory) diseases of the gastrointestinal tract.
-
10.
公开(公告)号:EP3569614A1
公开(公告)日:2019-11-20
申请号:EP18173245.4
申请日:2018-05-18
发明人: MEINEL, Lorenz , LÜHMANN, Tessa , BRAUN, Alexandra
IPC分类号: C07K14/65 , A61K38/30 , C12N9/10 , A61K38/18 , C07K14/475
摘要: The present invention relates to compounds and their use in the treatment of lesions, in tissue regeneration and/or tissue engineering. The compounds act as substrates for enzymes having transglutaminase activity and are suitable for their immobilization and/or attached therapeutic or diagnostic molecules on extracellular matrix (ECM) or synthetic ECM-derived materials, in particular for the immobilization of myostatin inhibitors.
-
-
-
-
-
-
-
-
-